Feasibility of neonatal dried blood spot retrieval amid evolving state policies (2009-2010): A Children's Oncology Group study

Amy M. Linabery, Megan E. Slater, Logan G. Spector, Andrew F. Olshan, Susan K. Stork, Michelle A. Roesler, Gregory H. Reaman, Julie A. Ross

Research output: Book/ReportBook

Abstract

Dried blood spots (DBS) are collected uniformly from US newborns to test for metabolic and other disorders. Because evidence exists for prenatal origins of some diseases, DBS may provide unique prenatal exposure records. Some states retain residual DBS and permit their use in aetiological studies. The primary study aim was to assess the feasibility of obtaining residual DBS from state newborn screening programmes for paediatric and adolescent cancer patients nationwide with parental/subject consent/assent. Families of leukaemia and lymphoma patients aged
Original languageEnglish (US)
Volume25
StatePublished - Aug 10 2011

Publication series

NamePaediatric and Perinatal Epidemiology
PublisherBlackwell Publishing Ltc
No.6
Volume25

Keywords

  • biological samples
  • consent
  • neonatal dried blood spots
  • research

Fingerprint Dive into the research topics of 'Feasibility of neonatal dried blood spot retrieval amid evolving state policies (2009-2010): A Children's Oncology Group study'. Together they form a unique fingerprint.

Cite this